Following the pandemic, industries began investing in personalized Customer Experience (CX) worldwide, including the life sciences commercial sector. To stay resilient and keep pace with the evolving landscape, the life sciences industry is adopting technology to differentiate for end-users. However, outdated tools and data fragmentation across business functions hinder enterprises from delivering personalized experiences. Currently, commercial technology in the life sciences industry primarily includes basic tools such as Customer Relationship Management (CRM) systems, content management systems, and marketing tools. These tools mainly serve as information repositories with limited insights into customers. Therefore, enterprises are enhancing these solutions with data analytics and AI/ML to develop customer-centric solutions that assist in targeted sales and effective messaging. This, in turn, boosts business performance and provides a competitive edge. Additionally, these solutions help internal stakeholders (such as IT departments, sales and marketing teams, and the medical affairs function) understand customer behavior and adapt their strategies accordingly. Scope: Industry: life sciences (biopharmaceuticals and medical devices) Geography: global Service: life sciences commercial technology Contents: In this report, we examine: Customer Experience Platforms (CXP) adoption market trends CXP adoption framework CXP landscape’s supplier ecosystem Implications for enterprises, service providers, and technology providers Membership(s) Life Sciences Information Technology Sourcing and Vendor Management

The COVID-19 pandemic, coupled with industry drivers such as the increasing preference for digital engagement and consumerism, has shifted life sciences enterprises’ investment priorities to Customer Experience (CX). Given that traditional Customer Relationship Management (CRM) platforms are not positioned to deliver a true hyper-personalized customer experience, this shift necessitates the move to a Customer Experience Platform (CXP), which can allow life sciences enterprises to not only ensure an optimal experience across all customer touchpoints, but also unlock business and operational benefits. CRM platform vendors, both cross-industry and life sciences-specific are looking to address this shift by developing end-to-end CXP functionalities with a focus on delivering a superior experience. In this report, we deep dive into the evolution of traditional CRM to CXP solutions, analyze adoption trends, and provide an overview of the CXP platforms available in the market. Scope Industry: life sciences Geography: global Contents This report studies: The life sciences industry’s shift to a customer-first approach The shift from traditional CRM to CXP The CXP supplier landscape Membership(s) Life Sciences Information Technology Sourcing and Vendor Management